MYL6B and neoplasm: Both miRNA-overexpression enhanced cell migration and invasion of tumor cells and cell migration and angiogenesis properties of HUVEC cells in the TME, so we speculate that MYL6B might be driving these phenotypes for miR526b and miR655.